Skip to main content

Want a detailed portfolio tracker?

Replimune Group (REPL) P/E (2018 - 2026)

Replimune Group (REPL) P/E from Jul 20, 2018 to Jul 21, 2026. The TTM Replimune Group (REPL) P/E is -2.78. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Replimune Group (REPL)

YearP/EChange
2026-2.78+15.36%
2025-2.41-33.80%
2024-3.65+48.22%
2023-2.46-72.67%
2022-9.00-23.57%
2021-11.78-43.42%
2020-20.82+89.12%
2019-11.01-12.82%
2018-12.63N/A

Comparison Replimune Group (REPL) P/E with competitors

Replimune Group (REPL) P/E is -2.78.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.15%
ENLVEnlivex Ltd0.07-102.69%
FGENFibroGen Inc0.24-108.62%
CHRSCoherus Biosciences Inc0.85-130.47%
FBIOFortress Biotech Inc0.95-134.08%
ORMPOramed Pharmaceuticals Inc1.50-153.97%
AGENAgenus Inc3.01-208.07%
INVAInnoviva Inc3.15-213.25%
VXRTVaxart Inc3.55-227.46%
CRMDCorMedix Inc3.63-230.29%
CVACCureVac N.V.4.45-259.63%
GLPGGalapagos NV4.86-274.47%
SRPTSarepta Therapeutics Inc4.88-275.30%
ABEOAbeona Therapeutics Inc5.39-293.45%
ABUSArbutus Biopharma Corp5.60-300.93%
ZVRAZevra Therapeutics Inc5.89-311.40%
SPROSpero Therapeutics Inc6.23-323.65%
CGENCompugen Ltd6.31-326.72%
RIGLRigel Pharmaceuticals6.87-346.76%
SLXNSilexion Therapeutics Corp7.30-361.98%
OMEROmeros Corporation9.26-432.46%
AUPHAurinia Pharmaceuticals Inc9.58-444.17%
PLXProtalix BioTherapeutics Inc10.89-491.07%
ACADAcadia Pharmaceuticals Inc11.73-521.14%
TBPHTheravance Biopharma Inc12.26-540.31%
ADMAAdma Biologics Inc12.42-545.91%
HRMYHarmony Biosciences Holdings Inc13.82-596.25%
SABSSAB Biotherapeutics Inc14.14-607.60%
NAGENiagen Bioscience Inc14.82-632.09%
INCYIncyte Corp15.82-668.15%
REGNRegeneron Pharmaceuticals Inc15.86-669.38%
PBYIPuma Biotechnology Inc17.32-721.77%
CPRXCatalyst Pharmaceuticals Inc17.44-726.21%
EXELExelixis Inc17.54-729.75%
TGTXTG Therapeutics Inc18.97-781.03%
MDXGMimedx Group Inc20.55-837.99%
XOMAXOMA Royalty Corp22.87-921.40%
ARGXArgen X SE24.30-972.51%
CTMXCytomX Therapeutics Inc24.82-991.29%
XOMAOXOMA Royalty Corp25.34-1010.10%
HALOHalozyme Therapeutics Inc25.62-1020.11%
XOMAPXOMA Royalty Corp25.67-1021.78%
VRTXVertex Pharmaceuticals Inc27.99-1105.25%
RPRXRoyalty Pharma plc - Class A28.69-1130.13%
SLNOSoleno Therapeutics Inc29.02-1141.90%
ASNDAscendis Pharma A/S30.09-1180.33%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1461.37%
APLSApellis Pharmaceuticals Inc39.02-1501.20%
BMRNBiomarin Pharmaceutical Inc42.21-1615.77%
KRYSKrystal Biotech Inc45.34-1728.22%
ONCBeiGene Ltd69.54-2597.11%
PHARPharming Group N.V.75.03-2794.07%
TECHBio-Techne Corp101.96-3761.19%
VCELVericel Corp109.92-4047.13%
ALNYAlnylam Pharmaceuticals Inc117.96-4335.98%
GMABGenmab140.29-5137.66%
TLXTelix Pharmaceuticals Ltd162.15-5922.70%
CORTCorcept Therapeutics Inc212.86-7743.44%